| Development, Optimization, and In Vitro/In Vivo Characterization of Enhanced Lipid Nanoparticles for Ocular Delivery of Ofloxacin: the Influence of Pegylation and … HM Eid, MH Elkomy, SF El Menshawe, HF Salem AAPS pharmscitech 20, 1-14, 2019 | 70 | 2019 |
| Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review MH Elkomy, AA Ali, HM Eid Journal of Controlled Release 351, 923-940, 2022 | 48 | 2022 |
| Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose … MH Elkomy, SF Elmenshawe, HM Eid, AMA Ali Drug delivery 23 (9), 3294-3306, 2016 | 48 | 2016 |
| Development of a nanogel formulation for transdermal delivery of tenoxicam: a pharmacokinetic–pharmacodynamic modeling approach for quantitative prediction of skin absorption MH Elkomy, SF El Menshawe, HM Eid, AMA Ali Drug development and industrial pharmacy 43 (4), 531-544, 2017 | 44 | 2017 |
| Novel chitosan-coated niosomal formulation for improved management of bacterial conjunctivitis: a highly permeable and efficient ocular nanocarrier for azithromycin HM Eid, IA Naguib, RI Alsantali, I Alsalahat, AM Hegazy Journal of Pharmaceutical Sciences 110 (8), 3027-3036, 2021 | 40 | 2021 |
| Surface-modified bilosomes nanogel bearing a natural plant alkaloid for safe management of rheumatoid arthritis inflammation MH Elkomy, NK Alruwaili, M Elmowafy, K Shalaby, A Zafar, N Ahmad, ... Pharmaceutics 14 (3), 563, 2022 | 37 | 2022 |
| Transfersomal nanovesicles for nose-to-brain delivery of ofloxacin for better management of bacterial meningitis: Formulation, optimization by Box-Behnken design … HM Eid, MH Elkomy, SF El Menshawe, HF Salem Journal of drug delivery science and technology 54, 101304, 2019 | 37 | 2019 |
| Lipid nanocarriers overlaid with chitosan for brain delivery of berberine via the nasal route HA Abo El-Enin, MH Elkomy, IA Naguib, MF Ahmed, OA Alsaidan, ... Pharmaceuticals 15 (3), 281, 2022 | 35 | 2022 |
| Berberine encapsulated lecithin–chitosan nanoparticles as innovative wound healing agent in type II diabetes DS Panda, HM Eid, MH Elkomy, A Khames, RM Hassan, FI Abo El-Ela, ... Pharmaceutics 13 (8), 1197, 2021 | 31 | 2021 |
| Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis MH Elkomy, M Elmowafy, K Shalaby, AF Azmy, N Ahmad, A Zafar, HM Eid Drug Development and Industrial Pharmacy 47 (2), 246-258, 2021 | 29 | 2021 |
| Potential use of tailored citicoline chitosan-coated liposomes for effective wound healing in diabetic rat model HM Eid, AA Ali, AMA Ali, EM Eissa, RM Hassan, FI Abo El-Ela, AH Hassan International Journal of Nanomedicine, 555-575, 2022 | 26 | 2022 |
| Intranasal delivery of granisetron to the brain via nanostructured cubosomes-based in situ gel for improved management of chemotherapy-induced emesis EM Eissa, MH Elkomy, HM Eid, AA Ali, MAS Abourehab, AM Alsubaiyel, ... Pharmaceutics 14 (7), 1374, 2022 | 22 | 2022 |
| Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: Improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats MH Elkomy, HM Eid, M Elmowafy, K Shalaby, A Zafar, MA Abdelgawad, ... Drug delivery 29 (1), 2694-2704, 2022 | 17 | 2022 |
| Fabrication and in vitro/in vivo appraisal of metronidazole intra-gastric buoyant sustained-release tablets in healthy volunteers MH Elkomy, HA Abou-Taleb, HM Eid, HA Yassin Pharmaceutics 14 (4), 863, 2022 | 9 | 2022 |
| Intranasal nanotransferosomal gel for quercetin brain targeting: I. Optimization, characterization, brain localization, and cytotoxic studies MH Elkomy, RM Zaki, OA Alsaidan, M Elmowafy, A Zafar, K Shalaby, ... Pharmaceutics 15 (7), 1805, 2023 | 7 | 2023 |
| Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures AS Tulbah, MH Elkomy, RM Zaki, HM Eid, EM Eissa, AA Ali, HA Yassin, ... International journal of pharmaceutics: X 6, 100206, 2023 | 5 | 2023 |
| Intranasal nanotransferosomal gel for quercetin brain targeting: II. Antidepressant effect in an experimental animal model MH Elkomy, FI Abo El-Ela, RM Zaki, OA Alsaidan, M Elmowafy, A Zafar, ... Pharmaceutics 15 (8), 2095, 2023 | 3 | 2023 |
| The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effects H Youssef, AF Azmy, HM Eid, OM Sayed, EB Eldomany, AA Farghali, ... International Microbiology, 1-13, 2024 | | 2024 |
| A Novel Chitosan-coated Leciplex Loaded with Ambrisentan as a Possible Pulmonary Nanosystem: Optimization, Characterization, and Pharmacokinetics Assessments HM Eid, TH Turkia, AA Ali, HM Aboud Journal of Pharmaceutical Sciences, 2024 | | 2024 |
Mohammed ElkomyJouf University, Beni Suef University在 ju.edu.sa 的电子邮件经过验证
